Follow the people · Insider
Patrick Burnett
Patrick Burnett files insider transactions with the SEC as an officer of Arcutis Biotherapeutics (ARQT). We hold 11 disclosed purchases and sales filed since 4 March 2019, 4 of them in the last 90 days.
- Files forARQT
- Disclosed buys and sells11 in all, 4 in the last 90 days
- Last disclosure21 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 3 August 2020 — 19 August 2026Officer · Arcutis Biotherapeutics (ARQT)113 Form 4 lines · source: SEC Form 4
- Filed 28 February 2019 — 27 February 2020Chief Medical Officer · Verrica Pharmaceuticals (VRCA)2 Form 4 lines · source: SEC Form 4
Everything they disclosed
115 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 1,697 shares of Arcutis BiotherapeuticsSEC Form 421 August 2026Common Stock · traded 19 August 2026 · filed 21 August 2026
- exercised options over 8,300 shares of Arcutis BiotherapeuticsSEC Form 413 August 2026Common Stock · traded 11 August 2026 · filed 13 August 2026
- ▼ sold on the open market 8,300 shares of Arcutis BiotherapeuticsSEC Form 413 August 2026Common Stock · traded 11 August 2026 · filed 13 August 2026
- exercised options over 6,700 shares of Arcutis BiotherapeuticsSEC Form 413 August 2026Common Stock · traded 12 August 2026 · filed 13 August 2026
- ▼ sold on the open market 6,700 shares of Arcutis BiotherapeuticsSEC Form 413 August 2026Common Stock · traded 12 August 2026 · filed 13 August 2026
- exercised options over 8,300 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 413 August 2026Stock Option (right to buy) · traded 11 August 2026 · filed 13 August 2026
- exercised options over 6,700 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 413 August 2026Stock Option (right to buy) · traded 12 August 2026 · filed 13 August 2026
- ▼ sold on the open market 955 shares of Arcutis BiotherapeuticsSEC Form 45 August 2026Common Stock · traded 3 August 2026 · filed 5 August 2026
- ▼ sold on the open market 222 shares of Arcutis BiotherapeuticsSEC Form 413 May 2026Common Stock · traded 11 May 2026 · filed 13 May 2026
- ▼ sold on the open market 684 shares of Arcutis BiotherapeuticsSEC Form 46 May 2026Common Stock · traded 4 May 2026 · filed 6 May 2026
- was granted 16,750 shares of Arcutis BiotherapeuticsSEC Form 43 March 2026Common Stock · traded 18 August 2022 · filed 3 March 2026
- was granted 30,000 shares of Arcutis BiotherapeuticsSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- ▼ sold on the open market 6,106 shares of Arcutis BiotherapeuticsSEC Form 43 March 2026Common Stock · traded 2 March 2026 · filed 3 March 2026
- was granted 77,000 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 43 March 2026Stock Option (right to buy) · traded 27 February 2026 · filed 3 March 2026
- ▼ sold on the open market 181 shares of Arcutis BiotherapeuticsSEC Form 43 March 2026Common Stock · traded 2 March 2026 · filed 3 March 2026
- was granted 77,000 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 43 March 2026Stock Option (right to buy) · traded 27 February 2026 · filed 3 March 2026
- was granted 16,750 shares of Arcutis BiotherapeuticsSEC Form 43 March 2026Common Stock · traded 18 August 2022 · filed 3 March 2026
- was granted 30,000 shares of Arcutis BiotherapeuticsSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- ▼ sold on the open market 6,106 shares of Arcutis BiotherapeuticsSEC Form 43 March 2026Common Stock · traded 2 March 2026 · filed 3 March 2026
- ▼ sold on the open market 181 shares of Arcutis BiotherapeuticsSEC Form 43 March 2026Common Stock · traded 2 March 2026 · filed 3 March 2026
- ▼ sold on the open market 3,675 shares of Arcutis BiotherapeuticsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 9,794 shares of Arcutis BiotherapeuticsSEC Form 44 February 2026Common Stock · traded 4 February 2026 · filed 4 February 2026
- ▼ sold on the open market 3,675 shares of Arcutis BiotherapeuticsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 9,794 shares of Arcutis BiotherapeuticsSEC Form 44 February 2026Common Stock · traded 4 February 2026 · filed 4 February 2026
- ▼ sold on the open market 2,490 shares of Arcutis BiotherapeuticsSEC Form 47 January 2026Common Stock · traded 5 January 2026 · filed 7 January 2026
- ▼ sold on the open market 2,490 shares of Arcutis BiotherapeuticsSEC Form 47 January 2026Common Stock · traded 5 January 2026 · filed 7 January 2026
- ▼ sold on the open market 541 shares of Arcutis BiotherapeuticsSEC Form 42 January 2026Common Stock · traded 31 December 2025 · filed 2 January 2026
- ▼ sold on the open market 1,156 shares of Arcutis BiotherapeuticsSEC Form 42 January 2026Common Stock · traded 31 December 2025 · filed 2 January 2026
- ▼ sold on the open market 541 shares of Arcutis BiotherapeuticsSEC Form 42 January 2026Common Stock · traded 31 December 2025 · filed 2 January 2026
- ▼ sold on the open market 1,156 shares of Arcutis BiotherapeuticsSEC Form 42 January 2026Common Stock · traded 31 December 2025 · filed 2 January 2026
- exercised options over 11,500 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 417 December 2025Stock Option (right to buy) · traded 15 December 2025 · filed 17 December 2025
- exercised options over 11,500 shares of Arcutis BiotherapeuticsSEC Form 417 December 2025Common Stock · traded 15 December 2025 · filed 17 December 2025
- ▼ sold on the open market 11,500 shares of Arcutis BiotherapeuticsSEC Form 417 December 2025Common Stock · traded 15 December 2025 · filed 17 December 2025
- exercised options over 17,250 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 410 November 2025Stock Option (right to buy) · traded 6 November 2025 · filed 10 November 2025
- exercised options over 17,250 shares of Arcutis BiotherapeuticsSEC Form 410 November 2025Common Stock · traded 6 November 2025 · filed 10 November 2025
- ▼ sold on the open market 17,250 shares of Arcutis BiotherapeuticsSEC Form 410 November 2025Common Stock · traded 6 November 2025 · filed 10 November 2025
- ▼ sold on the open market 2,607 shares of Arcutis BiotherapeuticsSEC Form 45 November 2025Common Stock · traded 3 November 2025 · filed 5 November 2025
- ▼ sold on the open market 15 shares of Arcutis BiotherapeuticsSEC Form 45 November 2025Common Stock · traded 3 November 2025 · filed 5 November 2025
- ▼ sold on the open market 3,864 shares of Arcutis BiotherapeuticsSEC Form 45 November 2025Common Stock · traded 5 November 2025 · filed 5 November 2025
- ▼ sold on the open market 1,750 shares of Arcutis BiotherapeuticsSEC Form 421 August 2025Common Stock · traded 19 August 2025 · filed 21 August 2025
- ▼ sold on the open market 2,438 shares of Arcutis BiotherapeuticsSEC Form 421 August 2025Common Stock · traded 21 August 2025 · filed 21 August 2025
- ▼ sold on the open market 3,847 shares of Arcutis BiotherapeuticsSEC Form 412 August 2025Common Stock · traded 8 August 2025 · filed 12 August 2025
- ▼ sold on the open market 2,622 shares of Arcutis BiotherapeuticsSEC Form 45 August 2025Common Stock · traded 4 August 2025 · filed 5 August 2025
- exercised options over 23,000 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 414 July 2025Stock Option (right to buy) · traded 10 July 2025 · filed 14 July 2025
- exercised options over 5,750 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 414 July 2025Stock Option (right to buy) · traded 14 July 2025 · filed 14 July 2025
- exercised options over 23,000 shares of Arcutis BiotherapeuticsSEC Form 414 July 2025Common Stock · traded 10 July 2025 · filed 14 July 2025
- ▼ sold on the open market 23,000 shares of Arcutis BiotherapeuticsSEC Form 414 July 2025Common Stock · traded 10 July 2025 · filed 14 July 2025
- exercised options over 5,750 shares of Arcutis BiotherapeuticsSEC Form 414 July 2025Common Stock · traded 14 July 2025 · filed 14 July 2025
- ▼ sold on the open market 5,750 shares of Arcutis BiotherapeuticsSEC Form 414 July 2025Common Stock · traded 14 July 2025 · filed 14 July 2025
- ▼ sold on the open market 3,871 shares of Arcutis BiotherapeuticsSEC Form 49 May 2025Common Stock · traded 8 May 2025 · filed 9 May 2025
- ▼ sold on the open market 2,597 shares of Arcutis BiotherapeuticsSEC Form 45 May 2025Common Stock · traded 2 May 2025 · filed 5 May 2025
- exercised options over 5,008 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 417 March 2025Stock Option (right to buy) · traded 13 March 2025 · filed 17 March 2025
- exercised options over 12,242 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 417 March 2025Stock Option (right to buy) · traded 14 March 2025 · filed 17 March 2025
- ▼ sold on the open market 44,153 shares of Arcutis BiotherapeuticsSEC Form 417 March 2025Common Stock · traded 13 March 2025 · filed 17 March 2025
- exercised options over 5,008 shares of Arcutis BiotherapeuticsSEC Form 417 March 2025Common Stock · traded 13 March 2025 · filed 17 March 2025
- ▼ sold on the open market 5,008 shares of Arcutis BiotherapeuticsSEC Form 417 March 2025Common Stock · traded 13 March 2025 · filed 17 March 2025
- exercised options over 12,242 shares of Arcutis BiotherapeuticsSEC Form 417 March 2025Common Stock · traded 14 March 2025 · filed 17 March 2025
- ▼ sold on the open market 12,242 shares of Arcutis BiotherapeuticsSEC Form 417 March 2025Common Stock · traded 14 March 2025 · filed 17 March 2025
- was granted 99,000 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 44 March 2025Stock Option (right to buy) · traded 28 February 2025 · filed 4 March 2025
- was granted 43,000 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 44 March 2025Stock Option (right to buy) · traded 28 February 2025 · filed 4 March 2025
- was granted 38,000 shares of Arcutis BiotherapeuticsSEC Form 44 March 2025Common Stock · traded 28 February 2025 · filed 4 March 2025
- was granted 17,000 shares of Arcutis BiotherapeuticsSEC Form 44 March 2025Common Stock · traded 28 February 2025 · filed 4 March 2025
- ▼ sold on the open market 2,819 shares of Arcutis BiotherapeuticsSEC Form 44 March 2025Common Stock · traded 3 March 2025 · filed 4 March 2025
- ▼ sold on the open market 954 shares of Arcutis BiotherapeuticsSEC Form 44 March 2025Common Stock · traded 4 March 2025 · filed 4 March 2025
- ▼ sold on the open market 12,116 shares of Arcutis BiotherapeuticsSEC Form 44 February 2025Common Stock · traded 3 February 2025 · filed 4 February 2025
- ▼ sold on the open market 1,691 shares of Arcutis BiotherapeuticsSEC Form 431 December 2024Common Stock · traded 31 December 2024 · filed 31 December 2024
- exercised options over 16,023 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 426 November 2024Stock Option (right to buy) · traded 22 November 2024 · filed 26 November 2024
- exercised options over 16,023 shares of Arcutis BiotherapeuticsSEC Form 426 November 2024Common Stock · traded 22 November 2024 · filed 26 November 2024
- ▼ sold on the open market 16,023 shares of Arcutis BiotherapeuticsSEC Form 426 November 2024Common Stock · traded 22 November 2024 · filed 26 November 2024
- exercised options over 18,377 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 418 November 2024Stock Option (right to buy) · traded 14 November 2024 · filed 18 November 2024
- exercised options over 100 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 418 November 2024Stock Option (right to buy) · traded 15 November 2024 · filed 18 November 2024
- ▼ sold on the open market 50,749 shares of Arcutis BiotherapeuticsSEC Form 418 November 2024Common Stock · traded 14 November 2024 · filed 18 November 2024
- exercised options over 18,377 shares of Arcutis BiotherapeuticsSEC Form 418 November 2024Common Stock · traded 14 November 2024 · filed 18 November 2024
- ▼ sold on the open market 18,377 shares of Arcutis BiotherapeuticsSEC Form 418 November 2024Common Stock · traded 14 November 2024 · filed 18 November 2024
- exercised options over 100 shares of Arcutis BiotherapeuticsSEC Form 418 November 2024Common Stock · traded 15 November 2024 · filed 18 November 2024
- ▼ sold on the open market 100 shares of Arcutis BiotherapeuticsSEC Form 418 November 2024Common Stock · traded 15 November 2024 · filed 18 November 2024
- ▼ sold on the open market 15,441 shares of Arcutis BiotherapeuticsSEC Form 45 November 2024Common Stock · traded 4 November 2024 · filed 5 November 2024
- ▼ sold on the open market 1,728 shares of Arcutis BiotherapeuticsSEC Form 421 August 2024Common Stock · traded 19 August 2024 · filed 21 August 2024
- ▼ sold on the open market 13,206 shares of Arcutis BiotherapeuticsSEC Form 45 August 2024Common Stock · traded 2 August 2024 · filed 5 August 2024
- exercised options over 23,000 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 431 May 2024Stock Option (right to buy) · traded 30 May 2024 · filed 31 May 2024
- ▼ sold on the open market 49,952 shares of Arcutis BiotherapeuticsSEC Form 431 May 2024Common Stock · traded 29 May 2024 · filed 31 May 2024
- exercised options over 23,000 shares of Arcutis BiotherapeuticsSEC Form 431 May 2024Common Stock · traded 30 May 2024 · filed 31 May 2024
- ▼ sold on the open market 23,000 shares of Arcutis BiotherapeuticsSEC Form 431 May 2024Common Stock · traded 30 May 2024 · filed 31 May 2024
- ▼ sold on the open market 9,555 shares of Arcutis BiotherapeuticsSEC Form 43 May 2024Common Stock · traded 2 May 2024 · filed 3 May 2024
- ▼ sold on the open market 4,782 shares of Arcutis BiotherapeuticsSEC Form 46 March 2024Common Stock · traded 4 March 2024 · filed 6 March 2024
- returned to the issuer 320,000 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 415 February 2024Stock Option (right to buy) · traded 13 February 2024 · filed 15 February 2024
- returned to the issuer 28,800 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 415 February 2024Stock Option (right to buy) · traded 13 February 2024 · filed 15 February 2024
- returned to the issuer 47,100 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 415 February 2024Stock Option (right to buy) · traded 13 February 2024 · filed 15 February 2024
- returned to the issuer 55,800 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 415 February 2024Stock Option (right to buy) · traded 13 February 2024 · filed 15 February 2024
- was granted 128,000 shares of Arcutis BiotherapeuticsSEC Form 415 February 2024Common Stock · traded 13 February 2024 · filed 15 February 2024
- was granted 9,600 shares of Arcutis BiotherapeuticsSEC Form 415 February 2024Common Stock · traded 13 February 2024 · filed 15 February 2024
- was granted 23,550 shares of Arcutis BiotherapeuticsSEC Form 415 February 2024Common Stock · traded 13 February 2024 · filed 15 February 2024
- was granted 27,900 shares of Arcutis BiotherapeuticsSEC Form 415 February 2024Common Stock · traded 13 February 2024 · filed 15 February 2024
- was granted 276,000 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 417 January 2024Stock Option (right to buy) · traded 12 January 2024 · filed 17 January 2024
- was granted 28,000 shares of Arcutis BiotherapeuticsSEC Form 417 January 2024Common Stock · traded 12 January 2024 · filed 17 January 2024
- ▼ sold on the open market 1,325 shares of Arcutis BiotherapeuticsSEC Form 43 January 2024Common Stock · traded 2 January 2024 · filed 3 January 2024
- ▼ sold on the open market 300 shares of Arcutis BiotherapeuticsSEC Form 422 August 2023Common Stock · traded 21 August 2023 · filed 22 August 2023
- ▼ sold on the open market 1,305 shares of Arcutis BiotherapeuticsSEC Form 422 August 2023Common Stock · traded 21 August 2023 · filed 22 August 2023
- ▼ sold on the open market 851 shares of Arcutis BiotherapeuticsSEC Form 48 March 2023Common Stock · traded 6 March 2023 · filed 8 March 2023
- was granted 55,800 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 46 March 2023Stock Option (Right to Buy) · traded 2 March 2023 · filed 6 March 2023
- ▼ sold on the open market 1,728 shares of Arcutis BiotherapeuticsSEC Form 46 March 2023Common Stock · traded 2 March 2023 · filed 6 March 2023
- ▼ sold on the open market 23 shares of Arcutis BiotherapeuticsSEC Form 46 March 2023Common Stock · traded 2 March 2023 · filed 6 March 2023
- was granted 21,000 shares of Arcutis BiotherapeuticsSEC Form 46 March 2023Common Stock · traded 2 March 2023 · filed 6 March 2023
- ▼ sold on the open market 1,475 shares of Arcutis BiotherapeuticsSEC Form 44 January 2023Common Stock · traded 3 January 2023 · filed 4 January 2023
- was granted 47,100 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 47 March 2022Stock Option (Right to Buy) · traded 3 March 2022 · filed 7 March 2022
- was granted 17,800 shares of Arcutis BiotherapeuticsSEC Form 47 March 2022Common Stock · traded 3 March 2022 · filed 7 March 2022
- ▼ sold on the open market 981 shares of Arcutis BiotherapeuticsSEC Form 47 March 2022Common Stock · traded 4 March 2022 · filed 7 March 2022
- ▼ sold on the open market 30 shares of Arcutis BiotherapeuticsSEC Form 47 March 2022Common Stock · traded 7 March 2022 · filed 7 March 2022
- was granted 16,750 shares of Arcutis BiotherapeuticsSEC Form 44 January 2022Common Stock · traded 30 December 2021 · filed 4 January 2022
- was granted 9,500 shares of Arcutis BiotherapeuticsSEC Form 45 March 2021Common Stock · traded 3 March 2021 · filed 5 March 2021
- was granted 28,800 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 45 March 2021Stock Option (Right to Buy) · traded 3 March 2021 · filed 5 March 2021
- was granted 320,000 shares of Arcutis Biotherapeutics (a derivative holding)SEC Form 45 August 2020Stock Option (Right to Buy) · traded 3 August 2020 · filed 5 August 2020
- was granted 33,500 shares of Arcutis BiotherapeuticsSEC Form 45 August 2020Common Stock · traded 3 August 2020 · filed 5 August 2020
- was granted 55,000 shares of Verrica Pharmaceuticals (a derivative holding)SEC Form 42 March 2020Employee Stock Option (Right to Buy) · traded 27 February 2020 · filed 2 March 2020
- was granted 52,508 shares of Verrica Pharmaceuticals (a derivative holding)SEC Form 44 March 2019Employee Stock Option (Right to Buy) · traded 28 February 2019 · filed 4 March 2019
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.